Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
for Fabry Disease
8 locations incl. Birmingham
Sponsor: UniQure Biopharma B.V.
Sex: Male·Age: 18 - 50
Code: NCT06270316·Phase 1, Phase 2·Recruiting·Listed Feb 2024
NYC Health + Hospitals/Metropolitan
Clinical research site in New York, New York · 1901 1ST AVE, ROOM #3M4, NEW YORK, NY 10029-7404 · (212) 423-7110 · Website
Part of NYC Health + Hospitals
As of July 2026, 1 paid clinical trial is recruiting at NYC Health + Hospitals/Metropolitan in New York, New York. Active studies at this site focus on Fabry Disease alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at NYC Health + Hospitals/Metropolitan (1)
More research sites in New York
- Memorial Sloan Kettering Cancer Center (460 trials)
- NYU Langone Health (304 trials)
- Icahn School of Medicine at Mount Sinai (257 trials)
- Columbia University Irving Medical Center (178 trials)
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) (157 trials)
- Weill Cornell Medicine (134 trials)
- Mount Sinai Hospital (121 trials)
- Columbia University Medical Center (119 trials)
- Columbia University (105 trials)
- Hospital for Special Surgery (66 trials)
Explore more
Paid clinical trials in New York, NY · New York clinical trials